Cargando…
Detection and targeting insulin growth factor receptor type 2 (IGF2R) in osteosarcoma PDX in mouse models and in canine osteosarcoma tumors
Osteosarcoma (OS) represents 3.4% of all childhood cancers with overall survival of 70% not improving in 30 years. The consistent surface overexpression of insulin-like growth factor-2 receptor (IGF2R) has been reported in commercial and patient-derived xenograft (PDX) OS cell lines. We aimed to ass...
Autores principales: | Karkare, Sharayu, Allen, Kevin J. H., Jiao, Rubin, Malo, Mackenzie E., Dawicki, Wojciech, Helal, Muath, Godson, Dale L., Dickinson, Ryan, MacDonald-Dickinson, Valerie, Yang, Rui, Hoang, Bang, Gorlick, Richard, Geller, David S., Dadachova, Ekaterina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685985/ https://www.ncbi.nlm.nih.gov/pubmed/31391495 http://dx.doi.org/10.1038/s41598-019-47808-y |
Ejemplares similares
-
Characterization of IGF2R Molecular Expression in Canine Osteosarcoma as Part of a Novel Comparative Oncology Approach
por: Boisclair, Charles, et al.
Publicado: (2023) -
Radioimmunotherapy Targeting IGF2R on Canine-Patient-Derived Osteosarcoma Tumors in Mice and Radiation Dosimetry in Canine and Pediatric Models
por: Broqueza, Jaline, et al.
Publicado: (2021) -
Novel Human Antibodies to Insulin Growth Factor 2 Receptor (IGF2R) for Radioimmunoimaging and Therapy of Canine and Human Osteosarcoma
por: Broqueza, Jaline, et al.
Publicado: (2021) -
Daratumumab-(225)Actinium conjugate demonstrates greatly enhanced antitumor activity against experimental multiple myeloma tumors
por: Dawicki, Wojciech, et al.
Publicado: (2019) -
Evaluation of P16 expression in canine appendicular osteosarcoma
por: Murphy, B. G., et al.
Publicado: (2017)